🔎 Trials Near Me

Home › Alzheimer's Disease › California › Los Angeles

Alzheimer's Disease clinical trials in Los Angeles, CA

14 studies for Alzheimer's Disease are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of LY3439539 in Participants With Alzheimer's Disease

RecruitingPhase 1
  • Inglewood Clinical, Los Angeles
Ages 50 to 85 · All sexes · Updated Sep 24, 2026 · NCT07598370

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

RecruitingPhase 3
  • USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC), Los Angeles
Ages 55 to 90 · All sexes · Updated Sep 22, 2026 · NCT06585787

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

RecruitingPhase 3
  • Inglewood Clinicals, Los Angeles
Ages 50 to 90 · All sexes · Updated Sep 21, 2026 · NCT07177352

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

RecruitingPhase 3
  • Inglewood Clinical, Los Angeles
Ages 60 to 85 · All sexes · Updated Sep 17, 2026 · NCT06976203

Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)

RecruitingPhase 1/2
  • UCLA TMS Clinical and Research Service, Los Angeles
Ages 55 to 100 · All sexes · Updated Sep 4, 2026 · NCT06597942

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

RecruitingPhase 2
  • Inglewood Clinical ( Site 1062), Los Angeles
Ages 50 to 85 · All sexes · Updated Aug 26, 2026 · NCT07033494

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

RecruitingPhase 3
  • University of California, Los Angeles (UCLA) - David Geffen School of Medicine, Los Angeles
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

RecruitingPhase 2/3Healthy volunteers welcome
  • University of Southern Califonria, Los Angeles
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT05552157

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

RecruitingPhase 2/3Healthy volunteers welcome
  • University of Southern Califonria, Los Angeles
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT06647498

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

RecruitingPhase 2
  • University of California at Los Angeles, Los Angeles
Ages 50 to 85 · All sexes · Updated Jun 26, 2026 · NCT07094516

Polyphenols and Cognitive Decline

RecruitingHealthy volunteers welcome
  • University of California, Los Angeles, Los Angeles
Ages 50 and older · All sexes · Updated Jun 11, 2026 · NCT06507254

[18F]PI-2620 Phase 3 Histopathological Study

RecruitingPhase 3
  • UC Los Angeles, Los Angeles
Ages 50 and older · All sexes · Updated May 22, 2026 · NCT05641688

Cardiac-Control Affecting Learning Through Mindfulness (CALM)

RecruitingHealthy volunteers welcome
  • University of Southern California, Los Angeles
Ages 50 to 70 · All sexes · Updated May 13, 2026 · NCT06410157

Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study

Recruiting
  • CSMC, Los Angeles
Ages 55 to 89 · All sexes · Updated Nov 19, 2025 · NCT07224607

About Alzheimer's Disease

Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. It's the most common cause of dementia among older adults.

More about Alzheimer's Disease on MedlinePlus

Alzheimer's Disease trials in other cities

Other studies in Los Angeles

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.